George Mason University has developed an AI-driven mobile app prototype for clinical documentation of bruises, aiming to aid survivors of violence.
Key Details
- 1George Mason University team created the Evidence-based AI Software for Injury Detection (EAS-ID) app, successfully completing Phase 1 prototype development.
- 2The app uses AI to capture and document bruises, guiding clinicians to produce images and records that meet clinical and legal standards.
- 3Initial funding of $4.85 million was received from an anonymous donor in March 2024.
- 4The app supports real-time guidance, image quality control, and standardized documentation, targeting frontline and forensic nursing professionals.
- 5AI training involves a large, diverse dataset, with a target of one million images collected; partnerships include Inova Health System and Adventist Healthcare.
- 6A crowdsourcing initiative will expand data beyond controlled clinical environments to improve real-world applicability.
Why It Matters
Standardized, AI-guided imaging for bruise documentation could enhance clinical and legal reliability for forensic nursing and clinicians, especially in sensitive cases like interpersonal violence. The project's scale and real-world data efforts signal potential for broader adoption of imaging AI in frontline care settings.
Source
EurekAlert
Related News
•EurekAlert
Deep Learning AI Outperforms Clinic Prognostics for Colorectal Cancer Recurrence
A new deep learning model using histopathology images identifies recurrence risk in stage II colorectal cancer more effectively than standard clinical predictors.
•EurekAlert
AI Reveals Key Health System Levers for Cancer Outcomes Globally
AI-based analysis identifies the most impactful policy and resource factors for improving cancer survival across 185 countries.
•EurekAlert
Dual-Branch Graph Attention Network Predicts ECT Success in Teen Depression
Researchers developed a dual-branch graph attention network that uses structural and functional MRI data to accurately predict individual responses to electroconvulsive therapy in adolescents with major depressive disorder.